Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China · Delayed Price · Currency is CNY 15.47
+0.23 (1.51%)
Aug 20, 2026, 3:00 PM CST
SHA:600535 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 8,149 | 8,236 | 8,498 | 8,674 | 8,637 | 7,952 |
Revenue Growth | -3.15% | -3.08% | -2.03% | 0.42% | 8.62% | -41.43% |
Gross Profit Gross Profit Growth | 5,407 | 5,494 | 5,688 | 5,789 | 5,490 | 5,269 |
Operating Income Operating Income Growth | 1,511 | 1,375 | 1,437 | 1,441 | 1,341 | 1,243 |
Net Income Net Income Growth | 1,223 | 1,105 | 955.59 | 1,071 | -264.24 | 2,359 |
Earnings Per Share EPS Growth | 0.82 | 0.74 | 0.64 | 0.72 | -0.18 | 1.57 |
EPS Growth | 14.15% | 15.63% | -11.16% | - | - | 109.33% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
Pharmaceutical Industry Pharmaceutical Industry Growth | 7,382 |
Pharmaceutical Commercial Pharmaceutical Commercial Growth | 765.76 |
Unallocated Other Unallocated Other Growth | 77.78 |
Total Total Growth | 8,225 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 4,354 | 4,234 | 3,518 | 4,751 | 4,244 | 3,791 |
Total Debt Total Debt Growth | 1,149 | 1,438 | 1,656 | 2,831 | 2,182 | 1,704 |
Net Cash (Debt) Net Cash Growth | 3,205 | 2,795 | 1,862 | 1,920 | 2,062 | 2,088 |
Net Cash Growth | 26.50% | 50.10% | -2.99% | -6.89% | -1.23% | - |
Net Cash Per Share Net Cash Per Share Growth | 2.15 | 1.87 | 1.25 | 1.29 | 1.40 | 1.39 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | - | 1,425 | 2,015 | 2,576 | 2,280 | 2,801 |
Capital Expenditures CapEx Growth | - | -381.26 | -564.94 | -668.82 | -404.41 | -571.73 |
Free Cash Flow Free Cash Flow Growth | - | 1,043 | 1,450 | 1,907 | 1,875 | 2,229 |
Free Cash Flow Growth | - | -28.02% | -23.98% | 1.68% | -15.89% | 61.28% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 66.34% | 66.70% | 66.94% | 66.74% | 63.56% | 66.27% |
Operating Margin | 18.54% | 16.70% | 16.91% | 16.61% | 15.52% | 15.63% |
Pretax Margin | 18.25% | 16.33% | 12.58% | 14.08% | -1.94% | 34.25% |
Profit Margin | 15.01% | 13.41% | 11.24% | 12.35% | -3.06% | 29.66% |
FCF Margin | - | 12.67% | 17.06% | 21.98% | 21.71% | 28.04% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.310 | 0.310 | 0.530 | 0.330 | 0.330 | 0.330 |
Dividend Per Share Growth | -41.51% | -41.51% | 60.61% | 0% | 0% | 0% |
Dividend Yield | 2.01% | 2.07% | 3.79% | 2.10% | 3.39% | 2.38% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 20, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.60 | 20.38 | 22.61 | 23.74 | - | 10.08 |
Forward PE | 12.39 | 12.94 | 15.72 | 7.47 | 4.03 | 8.30 |
P/FCF Ratio | 11.51 | 21.58 | 14.90 | 13.34 | 8.53 | 10.67 |
PS Ratio | 2.79 | 2.73 | 2.54 | 2.93 | 1.85 | 2.99 |